These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34733654)

  • 1. The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders.
    Cai S; Feng Y; Ye J; Deng Y; Cai Z; Zhu X; Liu R; Zhang Y; Zou Z; Tang Z; Han Z; Hon CT; Zhong W; He H
    Transl Androl Urol; 2021 Sep; 10(9):3579-3590. PubMed ID: 34733654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
    Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
    Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
    Sun X; Xin S; Jin L; Zhang Y; Ye L
    Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer.
    Zhu H; Chen H; Wang J; Zhou L; Liu S
    Onco Targets Ther; 2019; 12():3441-3457. PubMed ID: 31123405
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
    Chen MK; Chen ZJ; Xiao KH; Qin ZK; Ye YL; Wen WJ; Bian J; Xue KY; Zhou QZ; Guo WB; Zhou JH; Xia M; Li X; Liu CD
    Jpn J Clin Oncol; 2020 Apr; 50(4):456-464. PubMed ID: 31894237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients.
    Jiang L; Chen S; Pan Q; Zheng J; He J; Sun J; Han Y; Yang J; Zhang N; Fu G; Gao F
    BMC Cancer; 2022 Jun; 22(1):676. PubMed ID: 35725413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer.
    Xu F; Tang Q; Wang Y; Wang G; Qian K; Ju L; Xiao Y
    Front Genet; 2021; 12():758612. PubMed ID: 34938313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
    Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
    Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.
    Chan OTM; Furuya H; Pagano I; Shimizu Y; Hokutan K; Dyrskjøt L; Jensen JB; Malmstrom PU; Segersten U; Janku F; Rosser CJ
    Oncotarget; 2017 Nov; 8(59):99707-99721. PubMed ID: 29245935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
    Setti Boubaker N; Cicchillitti L; Said R; Gurtner A; Ayed H; Blel A; Karray O; Essid MA; Gharbi M; Bouzouita A; Rammeh Rommeni S; Chebil M; Piaggio G; Ouerhani S
    Mol Biol Rep; 2019 Oct; 46(5):4743-4750. PubMed ID: 31214962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
    Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aromatase in tumor related stroma is associated with human bladder cancer progression.
    Wu S; Ye J; Wang Z; Lin SX; Lu M; Liang Y; Zhu X; Olumi AF; Zhong WD; Wu CL
    Cancer Biol Ther; 2018 Mar; 19(3):175-180. PubMed ID: 29303414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
    Wang F; Dong X; Yang F; Xing N
    Front Genet; 2022; 13():831146. PubMed ID: 35419031
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
    Zheng Z; Lai C; Li W; Zhang C; Ma K; Yao Y
    Front Genet; 2021; 12():720421. PubMed ID: 34490046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
    Zhao X; Tang Y; Ren H; Lei Y
    Biomed Res Int; 2020; 2020():9143695. PubMed ID: 33204728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
    PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Yang D; Ma Y; Zhao P; Ma J; He C
    Biomed Pharmacother; 2019 Dec; 120():109433. PubMed ID: 31568988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer.
    Yang L; Sun HF; Guo LQ; Cao HB
    Cancer Manag Res; 2021; 13():7841-7850. PubMed ID: 34703308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
    Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.
    Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Ayed H; Saadi A; Naimi Z; Ksontini M; Ayadi M; Blel A; Rammeh S; Chebil M; Piaggio G; Ouerhani S
    Mol Biol Rep; 2020 Nov; 47(11):8819-8830. PubMed ID: 33128684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.